A humanized monoclonal antibody to carcinoembryonic antigen, labetuzumab, inhibits tumor growth and sensitizes human medullary thyroid cancer xenografts to dacarbazine chemotherapy

医学 癌胚抗原 癌症研究 单克隆抗体 达卡巴嗪 化疗 转移 抗体 癌症 药理学 免疫学 内科学 黑色素瘤
作者
Rhona Stein,David M. Goldenberg
出处
期刊:Molecular Cancer Therapeutics [American Association for Cancer Research]
卷期号:3 (12): 1559-1564 被引量:51
标识
DOI:10.1158/1535-7163.1559.3.12
摘要

A variety of observations have shown that carcinoembryonic antigen (CEA) is associated with growth and metastasis of cancers, including correlation of CEA serum levels with poor clinical outcome, mediation of cell-cell adhesion by CEA, and involvement of CEA in the immune recognition of tumors and apoptotic pathways. The purpose of this study was to investigate the effect that an anti-CEA monoclonal antibody (MAb) may have on the growth of medullary thyroid cancer (MTC), a CEA-expressing tumor, alone and in combination with chemotherapy. Antitumor effects were evaluated in a nude mouse-human MTC xenograft model. Using the TT MTC cell line grown s.c., we compared tumor growth in untreated mice with that of mice given the humanized anti-CEA MAb labetuzumab or an isotype-matched control MAb. The effects of time of administration post-tumor injection, MAb dose response, specificity of response, and combination with dacarbazine (DTIC) chemotherapy were studied. The humanized anti-CEA MAb, labetuzumab, has direct, specific, antitumor effects in this model, without conjugation to a cytotoxic agent. In addition, labetuzumab sensitizes these tumor cells to chemotherapy with an effective drug in this model, DTIC, without increased toxicity. Significant delays in tumor growth were caused by the MAb therapy or chemotherapy alone; however, the combination of these agents was significantly more effective than either agent given as a monotherapy or use of an irrelevant MAb in this model. The superiority of the combined modality treatment argues for the integration of CEA MAb therapy into chemotherapeutic regimens for MTC management and possibly other CEA-expressing neoplasms.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
jiajia完成签到,获得积分10
刚刚
光亮的代真完成签到 ,获得积分10
刚刚
XZJ发布了新的文献求助10
刚刚
兴奋石头发布了新的文献求助10
1秒前
巴拉巴拉发布了新的文献求助10
1秒前
1秒前
共享精神的应助被斩棘采纳,获得10
1秒前
2秒前
2秒前
httu完成签到,获得积分10
3秒前
4秒前
花无双完成签到,获得积分0
4秒前
科研通AI6.4的应助被四季西瓜采纳,获得10
5秒前
榕树完成签到,获得积分10
6秒前
霜双双完成签到,获得积分10
6秒前
Self完成签到,获得积分10
6秒前
seltzer完成签到,获得积分10
7秒前
jiajia发布了新的文献求助30
7秒前
今后的应助被高高惮采纳,获得10
7秒前
平常凛完成签到,获得积分10
7秒前
orixero的应助被qiqi采纳,获得10
8秒前
田螺姑娘完成签到,获得积分10
8秒前
8秒前
111111111111完成签到,获得积分10
8秒前
小马甲的应助被浮光采纳,获得30
9秒前
9秒前
9秒前
我是老大的应助被淡定的子默采纳,获得10
9秒前
Jun的应助被天空采纳,获得10
9秒前
9秒前
10秒前
Maestro_S的应助被clio采纳,获得10
10秒前
10秒前
BillyCHEN完成签到 ,获得积分10
11秒前
11秒前
zhouzhou完成签到,获得积分10
11秒前
过过过完成签到,获得积分20
12秒前
Youzi完成签到,获得积分10
13秒前
动听衬衫发布了新的文献求助10
13秒前
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187533
求助须知:如何正确求助?哪些是违规求助? 9575604
关于积分的说明 21842148
捐赠科研通 7785275
什么是DOI,文献DOI怎么找? 3434996
关于科研通互助平台的介绍 2559428
邀请新用户注册赠送积分活动 2481898